Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 6,958 shares at $310.08 ($2.2M) on 2026-02-13, disclosed to the SEC on 2026-02-17.
Open-market sale of $2.2M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $8.1M | — | Filing → |